Holocene Advisors, LP Zymeworks Inc. Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$27.35 - $37.28 $25.3 Million - $34.4 Million	-923,578 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.5 - $38.23 $8.45 Million - $12.2 Million	318,928 Added 52.75%	923,578 $32 Million
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $4.53 Million - $8.62 Million	151,775 Added 33.51%	604,650 $19.1 Million
Q4 2020 Feb 16, 2021	BUY	$39.12 - $54.99 $7.96 Million - $11.2 Million	203,513 Added 81.61%	452,875 $21.4 Million
Q3 2020 Nov 16, 2020	BUY	$29.21 - $46.58 $7.28 Million - $11.6 Million	249,362 New	249,362 $11.6 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $949M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.